129 related articles for article (PubMed ID: 24182219)
1. Prostate cancer screening.
Faigen M
Med J Aust; 2013 Nov; 199(9):585. PubMed ID: 24182219
[No Abstract] [Full Text] [Related]
2. Antibiotic resistance and transrectal prostate biopsies.
Davies RJ; Stephenson BM; Llewelyn M; Carter AC; Kubiak E
BMJ; 2013 Feb; 346():f1171. PubMed ID: 23444435
[No Abstract] [Full Text] [Related]
3. Prostate cancer screening and the management of clinically localized disease.
Wilt TJ; Ahmed HU
BMJ; 2013 Jan; 346():f325. PubMed ID: 23360718
[No Abstract] [Full Text] [Related]
4. [Prostate cancer screening].
Rodríguez-Carlin A; Castillo O
Medwave; 2016 Jul; 16(6):e6504. PubMed ID: 27532121
[No Abstract] [Full Text] [Related]
5. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
Jackson BR
Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
[No Abstract] [Full Text] [Related]
6. Alternative prostate cancer screening strategies.
Labrecque M; Aprikian A
Ann Intern Med; 2013 May; 158(10):778. PubMed ID: 23689773
[No Abstract] [Full Text] [Related]
7. Early detection of prostate cancer: can we have our cake and eat it too?
Masterson TA; Cary C; Cheng L
Expert Rev Anticancer Ther; 2016; 16(3):247-9. PubMed ID: 26760708
[No Abstract] [Full Text] [Related]
8. Alternative prostate cancer screening strategies--in response.
Gulati R; Etzioni R
Ann Intern Med; 2013 May; 158(10):778-9. PubMed ID: 23689774
[No Abstract] [Full Text] [Related]
9. Laurence Klotz on the Controversy Surrounding Screening for Prostate Cancer.
Klotz L
Oncology (Williston Park); 2016 Aug; 30(8):694, 764. PubMed ID: 27528237
[No Abstract] [Full Text] [Related]
10. Early detection of prostate cancer.
Taneja SS
Urol Clin North Am; 2014 May; 41(2):xi-xii. PubMed ID: 24725495
[No Abstract] [Full Text] [Related]
11. Probability, uncertainty, and prostate cancer.
Concato J
Ann Intern Med; 2013 Feb; 158(3):211-212. PubMed ID: 23381041
[No Abstract] [Full Text] [Related]
12. Prostate Cancer and the Evolving Role of Biomarkers in Screening and Diagnosis.
Rodriguez JF; Eggener SE
Radiol Clin North Am; 2018 Mar; 56(2):187-196. PubMed ID: 29420975
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer screening.
Eastham J
Investig Clin Urol; 2017 Jul; 58(4):217-219. PubMed ID: 28681029
[No Abstract] [Full Text] [Related]
14. MR Imaging for Prostate Cancer Screening and Active Surveillance.
Druskin SC; Macura KJ
Radiol Clin North Am; 2018 Mar; 56(2):251-261. PubMed ID: 29420980
[TBL] [Abstract][Full Text] [Related]
15. Editorial Comment to Active surveillance criteria for prostate cancer: can they be applied to Japanese patients?
Suzuki M
Int J Urol; 2012 Feb; 19(2):167-8. PubMed ID: 22092371
[No Abstract] [Full Text] [Related]
16. Words of wisdom: Re: Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: model estimates of potential benefits and harms.
Vickers A
Eur Urol; 2013 Oct; 64(4):682-3. PubMed ID: 23998500
[No Abstract] [Full Text] [Related]
17. The need for active surveillance for low risk prostate cancer.
Drost FH; Roobol MJ
Expert Rev Anticancer Ther; 2017 Jun; 17(6):487-489. PubMed ID: 28406334
[No Abstract] [Full Text] [Related]
18. Prostate-specific antigen dynamics and prostate cancer diagnosis.
Bartoletti R
Eur Urol; 2009 Nov; 56(5):761-2; discussion 763. PubMed ID: 19665286
[No Abstract] [Full Text] [Related]
19. Beyond the PSA test: How to better stratify a patient's risk of prostate cancer.
Lewis R; Hornberger B
JAAPA; 2017 Aug; 30(8):51-54. PubMed ID: 28742748
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of prostate cancer mortality in a Finnish randomized screening trial.
Neupane S; Steyerberg E; Raitanen J; Talala K; Pylväläinen J; Taari K; Tammela TL; Auvinen A
Int J Urol; 2018 Mar; 25(3):270-276. PubMed ID: 29224236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
